Sector News

Elementis to acquire SummitReheis for $360 million

February 13, 2017
Chemical Value Chain

Elementis has entered into an agreement to acquire SummitReheis (Hugenot, New York) from an affiliate of One Rock Capital Partners for $360 million.

SummitReheis produces a range of active ingredients and materials use in personal care, pharmaceutical and dental products. Its anti-perspirant actives business, which accounts for more than 60% of sales, is the global leader in this field and has long standing relationships with key consumer product companies across the Americas, Europe and Asia.

SummitReheis 2016 revenue is estimated at $134 million with EBITDA of approximately $28 million. The company’s primary manufacturing operations are in North America and Europe with approximately 70% of revenue derived from these markets. Elementis says the deal will expand its personal care business to approximately $200 million. The deal is expected to close in the second quarter following receipt of antitrust clearances in the US and Germany.

SummitReheis’ primary focus is the manufacture and sale of aluminum and zirconium based active ingredients for anti-perspirant products. In the pharma field, it produces active ingredients for indigestion and heartburn remedies and in the dental area it makes plasters, alloys, discs and molding materials that are used to make dental crowns, bridges, replacement teeth and in other applications.

By Natasha Alperowicz

Source: Chemical Week

comments closed

Related News

October 2, 2022

Trinseo announces potential closure of Boehlen, Germany Styrene Plant

Chemical Value Chain

Trinseo (NYSE: TSE), a specialty material solutions provider, announced it has initiated an information and consultation process with the Works Council of Trinseo Deutschland GmbH regarding the potential closure of its styrene monomer production site in Boehlen, Germany.

October 2, 2022

Celeste Mastin appointed H.B. Fuller President and CEO, succeeding Jim Owens upon his retirement

Chemical Value Chain

H.B. Fuller Company announced that Celeste Mastin, Executive Vice President and Chief Operating Officer, will succeed Jim Owens as H.B. Fuller’s President and Chief Executive Officer, effective December 4, 2022. Upon assuming the role, Mastin will also join the Company’s Board of Directors, replacing Owens, who will be retiring.

October 2, 2022

LyondellBasell realigns executive team, forms circular and low-carbon solutions business

Chemical Value Chain

New LyondellBasell CEO Peter Vanacker, who joined the company from Neste in May, today named his senior executive team and outlined organizational changes, including creation of a circular and low-carbon solutions business. All changes will be effective 1 October.